The Europe Colorectal Cancer Screening Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030).
Demand for colorectal cancer therapy is anticipated to rise significantly over time as the prevalence of colorectal cancer rises. Leading providers of colorectal cancer diagnostics are concentrating on developing efficient and optimal diagnostic solutions because they are essential to the disease's treatment. The diagnosis of colorectal cancer relies heavily on screening and imaging to determine the extent of the tumor-affected area. In the coming years, there will likely be a significant increase in demand for in-vitro diagnostics for colorectal cancer screening.
The market is expanding significantly because of increasing awareness regarding colorectal cancer early detection. The early stages of colorectal cancer are being detected and monitored using a variety of screening and diagnostic methods, such as colonoscopy and biomarker testing. Technological developments and stakeholder collaborations are driving market expansion. Improving screening accuracy, sensitivity, and specificity are priorities to improve patient outcomes. The market is expected to experience significant growth owing to rising incidence rates and continuous research, which will enhance patient treatment and lower mortality rates.
In the United Kingdom, the government offers bowel cancer screening every two years to men and women aged 60 to 74. The elderly can request a screening kit every two years by calling the free helpline. In addition, ministers agreed in August 2018 that the screening age for bowel cancer in England will increase to 50. From April 2021, the National Health Service (NHS) lowered the age range for bowel cancer screenings. This regional market is anticipated to expand due to the aging populations in European nations and the government's favourable attitude toward cancer screening.
The Germany market dominated the Europe Colorectal Cancer Screening Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,392.4 million by 2030. The UK market is estimated to witness a CAGR of 3.5% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 5.2% during (2023 - 2030).
Based on Type, the market is segmented into Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), and Others. Based on End-user, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Colorectal Cancer Screening Market is Projected to reach USD 22.2 Billion by 2030, at a CAGR of 4.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers AG (Siemens AG).
Scope of the Study
Market Segments Covered in the Report:
By Type
- Fecal Immunochemical Test (FIT)
- Fecal Occult Blood Test (FOBT)
- Stool-DNA Test
By End-user
- Hospitals & Clinics
- Clinical Laboratories
- Diagnostic Imaging Centres
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Novigenix SA
- Eiken Chemical Co., Ltd.
- Clinical Genomics Pathology, Inc.
- Exact Sciences Corporation
- Epigenomics AG
- BioMerieux S.A.
- Olympus Corporation
- Sysmex Corporation
- Fujifilm Holdings Corporation
- Siemens Healthineers AG (Siemens AG)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Colorectal Cancer Screening Market, by Type
1.4.2 Europe Colorectal Cancer Screening Market, by End-user
1.4.3 Europe Colorectal Cancer Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Colorectal Cancer Screening Market by Type
5.1 Europe Colonoscopy Market by Country
5.2 Europe Stool-based Market by Country
5.3 Europe Colorectal Cancer Screening Market by Stool-based Type
5.3.1 Europe Fecal Immunochemical Test (FIT) Market by Country
5.3.2 Europe Fecal Occult Blood Test (FOBT) Market by Country
5.3.3 Europe Stool-DNA Test Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Colorectal Cancer Screening Market by End-user
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Clinical Laboratories Market by Country
6.3 Europe Diagnostic Imaging Centres Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Colorectal Cancer Screening Market by Country
7.1 Germany Colorectal Cancer Screening Market
7.1.1 Germany Colorectal Cancer Screening Market by Type
7.1.1.1 Germany Colorectal Cancer Screening Market by Stool-based Type
7.1.2 Germany Colorectal Cancer Screening Market by End-user
7.2 UK Colorectal Cancer Screening Market
7.2.1 UK Colorectal Cancer Screening Market by Type
7.2.1.1 UK Colorectal Cancer Screening Market by Stool-based Type
7.2.2 UK Colorectal Cancer Screening Market by End-user
7.3 France Colorectal Cancer Screening Market
7.3.1 France Colorectal Cancer Screening Market by Type
7.3.1.1 France Colorectal Cancer Screening Market by Stool-based Type
7.3.2 France Colorectal Cancer Screening Market by End-user
7.4 Russia Colorectal Cancer Screening Market
7.4.1 Russia Colorectal Cancer Screening Market by Type
7.4.1.1 Russia Colorectal Cancer Screening Market by Stool-based Type
7.4.2 Russia Colorectal Cancer Screening Market by End-user
7.5 Spain Colorectal Cancer Screening Market
7.5.1 Spain Colorectal Cancer Screening Market by Type
7.5.1.1 Spain Colorectal Cancer Screening Market by Stool-based Type
7.5.2 Spain Colorectal Cancer Screening Market by End-user
7.6 Italy Colorectal Cancer Screening Market
7.6.1 Italy Colorectal Cancer Screening Market by Type
7.6.1.1 Italy Colorectal Cancer Screening Market by Stool-based Type
7.6.2 Italy Colorectal Cancer Screening Market by End-user
7.7 Rest of Europe Colorectal Cancer Screening Market
7.7.1 Rest of Europe Colorectal Cancer Screening Market by Type
7.7.1.1 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type
7.7.2 Rest of Europe Colorectal Cancer Screening Market by End-user
Chapter 8. Company Profiles
8.1 Novigenix SA
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Eiken Chemical Co., Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.3 Clinical Genomics Pathology, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Exact Sciences Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Epigenomics AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 BioMerieux S.A.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Olympus Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sysmex Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Siemens Healthineers AG (Siemens AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.4.1 Acquisition and Mergers:
8.9.5 SWOT Analysis
8.10. Fujifilm Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Geographical Expansions:
8.10.6 SWOT Analysis
TABLE 1 Europe Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 2 Europe Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Colorectal Cancer Screening Market
TABLE 4 Product Launches And Product Expansions– Colorectal Cancer Screening Market
TABLE 5 Acquisition and Mergers– Colorectal Cancer Screening Market
TABLE 6 Geographical Expansions- Colorectal Cancer Screening Market
TABLE 7 Europe Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 8 Europe Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 9 Europe Colonoscopy Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Colonoscopy Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Stool-based Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Stool-based Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 14 Europe Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 15 Europe Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Stool-DNA Test Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Stool-DNA Test Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 24 Europe Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 25 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Clinical Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Clinical Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
TABLE 35 Germany Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 36 Germany Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 37 Germany Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 38 Germany Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 39 Germany Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 40 Germany Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 41 Germany Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 42 Germany Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 43 UK Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 44 UK Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 45 UK Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 46 UK Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 47 UK Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 48 UK Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 49 UK Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 50 UK Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 51 France Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 52 France Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 53 France Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 54 France Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 55 France Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 56 France Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 57 France Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 58 France Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 59 Russia Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 60 Russia Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 61 Russia Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 62 Russia Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 63 Russia Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 64 Russia Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 65 Russia Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 66 Russia Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 67 Spain Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 68 Spain Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 69 Spain Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 70 Spain Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 71 Spain Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 72 Spain Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 73 Spain Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 74 Spain Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 75 Italy Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 76 Italy Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 77 Italy Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 78 Italy Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 79 Italy Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 80 Italy Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 81 Italy Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 82 Italy Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 83 Rest of Europe Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 84 Rest of Europe Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 85 Rest of Europe Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 86 Rest of Europe Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 87 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 88 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 89 Rest of Europe Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 90 Rest of Europe Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 91 Key Information – Novigenix SA
TABLE 92 Key Information – Eiken Chemical Co., Ltd.
TABLE 93 Key Information – Clinical Genomics Pathology, Inc.
TABLE 94 Key Information – Exact Sciences Corporation
TABLE 95 Key Information – Epigenomics AG
TABLE 96 Key Information – BioMerieux S.A.
TABLE 97 Key Information – Olympus Corporation
TABLE 98 Key Information – Sysmex Corporation
TABLE 99 Key Information – Siemens Healthineers AG
TABLE 100 Key Information – Fujifilm Holdings Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Colorectal Cancer Screening Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors Colorectal Cancer Screening Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis – Colorectal Cancer Screening Market
FIG 8 Europe Colorectal Cancer Screening Market share by Type, 2022
FIG 9 Europe Colorectal Cancer Screening Market share by Type, 2030
FIG 10 Europe Colorectal Cancer Screening Market by Type, 2019 - 2030, USD Million
FIG 11 Europe Colorectal Cancer Screening Market share by End-user, 2022
FIG 12 Europe Colorectal Cancer Screening Market share by End-user, 2030
FIG 13 Europe Colorectal Cancer Screening Market by End-user, 2019 - 2030, USD Million
FIG 14 Europe Colorectal Cancer Screening Market share by Country, 2022
FIG 15 Europe Colorectal Cancer Screening Market share by Country, 2030
FIG 16 Europe Colorectal Cancer Screening Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Novigenix SA
FIG 18 SWOT Analysis: Clinical Genomics Pathology, Inc.
FIG 19 SWOT Analysis: Exact Sciences Corporation
FIG 20 SWOT Analysis: Epigenomics AG
FIG 21 SWOT Analysis: BioMerieux S.A.
FIG 22 Recent strategies and developments: Olympus Corporation
FIG 23 SWOT Analysis: Olympus Corporation
FIG 24 SWOT Analysis: Sysmex Corporation
FIG 25 SWOT Analysis: Siemens Healthineers AG
FIG 26 Recent strategies and developments: Fujifilm Holdings Corporation
FIG 27 SWOT Analysis: Fujifilm Holdings Corporation